Literature DB >> 27689627

Incidence Rate of Prediabetes Progression to Diabetes: Modeling an Optimum Target Group for Intervention.

Ramona S DeJesus1,2, Carmen Radecki Breitkopf3, Lila J Rutten1,4, Debra J Jacobson5, Patrick M Wilson5, Jennifer St Sauver1,4.   

Abstract

Thirty-seven percent of US adults have prediabetes. Various interventions can delay diabetes progression; however, the optimum target group for risk reduction is uncertain. This study estimated rate of progression to diabetes at 1 and 5 years among a cohort of patients from 3 primary care clinics and modeled the potential magnitude in diabetes incidence risk reduction of an intervention program among specific subgroups. Records of 106,821 empaneled patients in 2005 were reviewed. Generalized population attributable risk (PAR) statistics were calculated to estimate the impact of reducing fasting blood glucose on diabetes progression. Multiple intervention effects (varying levels of glucose reduction along with multiple adherence rates) were examined for those with baseline glucose from 110 to 119 mg/dL and ≥120 mg/dL. Ten percent of patients (n = 10,796) met criteria for prediabetes. The 1- and 5-year diabetes incidence rate was 38.6 and 40.24 per 1000 person-years, respectively. Age and obesity were independent predictors of increased progression rate. The generalized PAR for a 10-point reduction in the 110-119 mg/dL subgroup with 25% adherence was 7.6%. The generalized PAR for similar percent reduction and adherence level in patients with baseline glucose of ≥120 mg/dL was only 3.0%. Rate of progression to diabetes increased over time and with associated independent risk factors. Greater risk reduction in diabetes progression within the target population can be achieved when the intervention is successful in those with baseline glucose of 110-119 mg/dL. Modeling an optimum target group for a diabetes prevention intervention offers a novel and useful guide to planning and allocating resources in population health management.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27689627     DOI: 10.1089/pop.2016.0067

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  13 in total

1.  Using an optimized generative model to infer the progression of complications in type 2 diabetes patients.

Authors:  Xiaoxia Wang; Yifei Lin; Yun Xiong; Suhua Zhang; Yanming He; Yuqing He; Zhikun Zhang; Joseph M Plasek; Li Zhou; David W Bates; Chunlei Tang
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-01       Impact factor: 3.298

2.  Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.

Authors:  Ayush Sharma; Harika Kandlakunta; Sajan Jiv Singh Nagpal; Ziding Feng; William Hoos; Gloria M Petersen; Suresh T Chari
Journal:  Gastroenterology       Date:  2018-06-11       Impact factor: 22.682

3.  Comparison of 3 risk factor-based screening tools for the identification of prediabetes.

Authors:  Courtney E Gamston; Anna N Kirby; Richard A Hansen; David T Redden; Heather P Whitley; Courtney Hanson; Kimberly B Lloyd
Journal:  J Am Pharm Assoc (2003)       Date:  2019-12-27

4.  Impact of a 12-week wellness coaching on self-care behaviors among primary care adult patients with prediabetes.

Authors:  Ramona S DeJesus; Matthew M Clark; Lila J Finney Rutten; Robert M Jacobson; Ivana T Croghan; Patrick M Wilson; Debra J Jacobson; Sara M Link; Chun Fan; Jennifer L St Sauver
Journal:  Prev Med Rep       Date:  2018-02-21

5.  Type 2 Diabetes Prevention Focused on Normalization of Glycemia: A Two-Year Pilot Study.

Authors:  Amy L McKenzie; Shaminie J Athinarayanan; Jackson J McCue; Rebecca N Adams; Monica Keyes; James P McCarter; Jeff S Volek; Stephen D Phinney; Sarah J Hallberg
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

6.  Progression to Diabetes Among Older Adults With Hemoglobin A1c-Defined Prediabetes in the US.

Authors:  Alain K Koyama; Kai McKeever Bullard; Meda E Pavkov; Joohyun Park; Russ Mardon; Ping Zhang
Journal:  JAMA Netw Open       Date:  2022-04-01

7.  The effect of cassia seed extract on the regulation of the LKB1-AMPK-GLUT4 signaling pathway in the skeletal muscle of diabetic rats to improve the insulin sensitivity of the skeletal muscle.

Authors:  Qiu-Ying Wang; Ai-Hua Tong; Ying-Ying Pan; Xian-Dang Zhang; Wen-Yu Ding; Wen Xiong
Journal:  Diabetol Metab Syndr       Date:  2019-12-19       Impact factor: 3.320

8.  Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea.

Authors:  Jin-Hee Lee; Suk Chon; Seon-Ah Cha; Sun-Young Lim; Kook-Rye Kim; Jae-Seung Yun; Sang Youl Rhee; Kun-Ho Yoon; Yu-Bae Ahn; Jeong-Taek Woo; Seung-Hyun Ko
Journal:  Korean J Intern Med       Date:  2020-03-05       Impact factor: 2.884

9.  Survey of Primary Care Physicians' Screening and Treatment Practices for Prediabetes in Saudi Arabia.

Authors:  Faisal Aljehani; Abdullah Alsulaiman; Abdulrahim Alqarni; Fahad Almutairi; May Samkari
Journal:  Cureus       Date:  2022-01-21

10.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.